Brand
Shockwave
Shockwave makes circulatory restoration products for calcified coronary and peripheral artery disease. Johnson & Johnson's fiscal 2025 Form 10-K places it in the MedTech cardiovascular portfolio.
Also searched as Shockwave Medical.
Documented stakes
The fiscal 2025 Form 10-K describes Shockwave as part of the MedTech cardiovascular portfolio. It does not restate a percentage.
As of Dec 28, 2025. Last checked Sep 22, 2026.
- Johnson & Johnson Form 10-K for the fiscal year ended December 28, 2025 · U.S. Securities and Exchange Commission